Iukary Takenami
Universidade Federal do Vale do São Francisco
35 Papers
147 Citations
Iukary Takenami is an academic researcher from Universidade Federal do Vale do São Francisco. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 7, co-authored 24 publications. Previous affiliations of Iukary Takenami include Oswaldo Cruz Foundation.
Chat about Author
Papers
Pandemia da COVID-19: o maior desafio do século XXI
Sávio Breno Pires Brito,Isaque Oliveira Braga,Carolina Coelho Cunha,Maria Augusta Vasconcelos Palácio,Iukary Takenami +4 more
- 28 Apr 2020
TL;DR: A narrative review of the literature showed that the origin of SARS-CoV-2, the causative agent of COVID-19, is uncertain and the rapid spread of the virus may be related to the form of transmission and its ability to survive in the external environment.
•Journal Article
Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay.
Almério Machado,Emodi K,Iukary Takenami,Brooke Finkmoore,Theolis Barbosa,J. Carvalho,Cavalcanti L,Santos G,Maria Solange Guarino Tavares,M. Mota,Barreto F,Mitermayer G. Reis,Sérgio Arruda,Lee W. Riley +13 more
TL;DR: In a setting endemic for TB, TST results appear to be more suitable in the decision to treat latent TB infection.
Em tempos de pandemia pela COVID-19: o desafio para a educação em saúde
Maria Augusta Vasconcelos Palácio,Iukary Takenami +1 more
- 28 Apr 2020
TL;DR: Reflection on the challenges and perspectives of health education in the face of the pandemic of disease caused by the new coronavirus 2019 (COVID-19) finds that the classic forms of prevention, such as isolation and the adoption of hygiene habits by the population, still face barriers to be implemented.
•Journal Article
Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
Almério Machado,Brooke Finkmoore,Krisztina Emodi,Iukary Takenami,Theolis Barbosa,Maria Solange Guarino Tavares,Mitermayer G. Reis,Sérgio Arruda,Lee W. Riley +8 more
TL;DR: Completion of LTBI treatment was most affected by medication intolerance and commuting difficulties for follow-up visits, and nearly 50% of HHCs at high risk for developing TB completed a 6-month course ofLTBI treatment.
Immunoglobulin G response to mammalian cell entry 1A (Mce1A) protein as biomarker of active tuberculosis
Iukary Takenami,Carolina Cavalcante de Oliveira,Filipe R Lima,Filipe R Lima,Jéssica Soares,Jéssica Soares,Almério Machado,Lee W. Riley,Sérgio Arruda,Sérgio Arruda +9 more
TL;DR: Results suggest that circulating total IgG antibody to Mce1A could be a complementary tool to diagnosis and monitoring tuberculosis (TB) treatment response.
16